About
Technology
Issues
FAQ
Links
Official Page
Osimertinib in patients with T790M mutation‐positive, advanced non–small cell lung cancer: Long‐term follow‐up from a pooled analysis of 2 phase 2 studies
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.